Author:
Kramer James,Obejero-Paz Carlos A.,Myatt Glenn,Kuryshev Yuri A.,Bruening-Wright Andrew,Verducci Joseph S.,Brown Arthur M.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals (2005 October).
2. Sanguinetti, M. C., Jiang, C., Curran, M. E. & Keating, M. T. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 81, 299–307 (1995).
3. Roy, M., Dumaine, R. & Brown, A. M. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation. 94, 817–823 (1996).
4. Suessbrich, H., Waldegger, S., Lang, F. & Busch, A. E. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett. 385, 77–80 (1996).
5. Sager, P. T. Key clinical considerations for demonstrating the utility of preclinical models to predict clinical drug-induced torsades de pointes. Br. J. Pharmacol. 154, 1544–1549 (2008).
Cited by
282 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献